0001415889-24-003811.txt : 20240214
0001415889-24-003811.hdr.sgml : 20240214
20240214183648
ACCESSION NUMBER: 0001415889-24-003811
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stevens Jennifer
CENTRAL INDEX KEY: 0001982621
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39813
FILM NUMBER: 24641277
MAIL ADDRESS:
STREET 1: C/O TRISALUS LIFE SCIENCES, INC.
STREET 2: 6272 W. 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TriSalus Life Sciences, Inc.
CENTRAL INDEX KEY: 0001826667
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 853009869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
BUSINESS PHONE: 415 336 8917
MAIL ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
FORMER COMPANY:
FORMER CONFORMED NAME: MedTech Acquisition Corp
DATE OF NAME CHANGE: 20200930
4
1
form4-02142024_110203.xml
X0508
4
2024-02-12
0001826667
TriSalus Life Sciences, Inc.
TLSI
0001982621
Stevens Jennifer
6272 W. 91ST AVENUE
WESTMINSTER
CO
80031
false
true
false
false
CHIEF REGULATORY OFFICER
0
Common Stock
2024-02-12
4
A
0
14752
0
A
32783
D
Employee Stock Option (right to buy)
9.50
2024-02-12
4
A
0
63750
0
A
2034-02-11
Common Stock
63750
63750
D
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
/s/ Sean Murphy, Attorney-in-Fact
2024-02-14